Dermatology Associates of Rochester
100 White Spruce Boulevard
Rochester, NY 14623
Phone: (585) 272-0700
Fax: (585) 272-8356
Mon–Fri: 8 a.m.–5 p.m.
Dermatology Associates of Rochester
,
Phone: (585) 272-9346
Fax: (585) 272-7592
Mon: 9 a.m.–5 p.m.
Tues, Wed, Thurs: 9 a.m.–7 p.m.
Fri: 9 a.m.–6 p.m.
Sat: 8 a.m.–12:30 p.m.
*Or after last appointment
Dermatology Associates of Rochester
,
Phone: (585) 697-1818
Fax: (585) 697-0822
Mon–Fri: 8 a.m.–5 p.m.
Dr. Kassie Haitz is a board-certified dermatologist who has been serving the Rochester community for more than 10 years. She provides comprehensive dermatologic care, with expertise in medical, surgical, and cosmetic dermatology. Her clinical interests include acne, psoriasis and other inflammatory skin diseases, skin cancer detection and treatment, pediatric dermatology, and cosmetic laser procedures.
Originally from Batavia, New York, Dr. Haitz graduated magna cum laude and was elected to Phi Beta Kappa at SUNY Geneseo, where she earned her degree in biology. She received her medical degree from the University at Buffalo School of Medicine and Biomedical Sciences and went on to complete a research fellowship in dermatology in Houston, Texas. She then trained in dermatology at the prestigious Dartmouth-Hitchcock Medical Center, where she served as Chief Resident.
In addition to her clinical practice, Dr. Haitz is an accomplished researcher. She has participated in numerous clinical trials for psoriasis and other skin diseases and has published extensively in respected dermatology journals as well as leading dermatology textbooks.
Her approach to patient care emphasizes prevention, education, and natural results. She believes cosmetic treatments should enhance a patient’s own features while keeping skin healthy and youthful-looking.
Outside of medicine, Dr. Haitz leads an active life with her husband, who is also a physician, and their three children. She enjoys yoga, pilates, golf, tennis, hiking, skiing, and travel.
We established Dermatology Associates of Rochester to provide quality, compassionate medical and cosmetic skincare and plastic surgery services in a boutique setting where patients felt like part of an extended family. Our board-certified dermatologists, plastic surgeon, nurse practitioners, and registered nurses work together with our professional staff to ensure you enjoy an exceptional experience each time you visit.
Meet the TeamAmerican Board of Dermatology
American Academy of Dermatology (AAD) 2012-Present
Dartmouth-Hitchcock Medical Center
Residency in Dermatology 2012- 2015
Lebanon, NH
Center for Clinical Studies
Clinical Research Fellowship in Dermatology 2010-2011
Houston, TX
University at Buffalo, Department of Medicine
Internship in Internal Medicine 2009-2010
Buffalo, NY
University at Buffalo School of Medicine and Biomedical Sciences
Medical Doctor (MD) 2009
Buffalo, NY
State University of New York At Geneseo
Bachelors of Science (BS), Biology, Magna Cum Laude 2005
Geneseo, NY
September 2013–June 2015 Dartmouth-Hitchcock Medical Center, Lebanon, NH
Principal Investigator, M. Shane Chapman, MD
Sub-investigator for a phase 3, multi-site, open-label study of the long term safety and tolerability of 2 oral doses of CP-690,550 (Tofacitinib) in subjects with moderate to severe chronic plaque psoriasis.
September 2013–June 2015 Dartmouth-Hitchcock Medical Center, Lebanon, NH
Principal Investigator, M. Shane Chapman, MD
Sub-investigator for a phase 3b, randomized, double-blind, active-controlled, multicenter study of ustekinumab to evaluate a “subject-tailored” maintenance dosing approach in subjects with moderate-to-severe plaque psoriasis.
October 2012–June 2015 Dartmouth-Hitchcock Medical Center, Lebanon, NH
Principal Investigator, M. Shane Chapman, MD Sub-investigator for a phase 3B, multicenter, randomized, placebo-controlled, double-blind, double-dummy, study of the efficacy and safety of apremilast, etanercept, and placebo, in subjects with moderate to severe plaque psoriasis.
September 2010 –June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III, multicenter, randomized, vehicle-controlled double-blind study of efficacy and safety of calcitriol topical aerosol applied twice daily for 8 weeks in subjects with plaque type psoriasis.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBASub-investigator for an open label, mechanism of action, study of sinecatechins ointment in patients with external genital warts.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of adding topical clobetasol to etanercept in subjects with moderate to severe plaque psoriasis.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBASub-investigator for a phase III, multicenter, study comparing calcipotriol plus betamethasone dipropionate in a topical suspension with placebo for subjects with psoriasis vulgaris in non-scalp regions of the body.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III, multicenter, open-label study of long-term safety and tolerability of tasocitinib, a JAK-3 inhibitor, in subjects with moderate to severe chronic plaque psoriasis.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase II, multicenter, double-blind, randomized, placebo controlled dose finding study of oral AEB071, a protein kinase C inhibitor, assessing PASI response in patients with plaque psoriasis.
September 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase II multicenter, randomized, double-blind, controlled study to evaluate safety tolerability and preliminary efficacy of two capsaicin concentrationsvariations of NGX-1998 in subjects with postherpetic neuralgia.
August 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase IV, multicenter, randomized, non-therapeutic interventional trial evaluating the prevalence of psoriatic arthritis in adults with psoriasis.
August 2009 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III, multi-center, open–label continuation study in moderate to severe chronic plaque psoriasis in subjects who completed a preceding psoriasis study with ABT-874, an anti-IL-12/23 antibody.
July 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adding methotrexate to etanercept in subjects with moderate to severe plaque psoriasis.
July 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase III multicenter, double-blind, randomized, placebo controlled trial evaluating the efficacy and safety of alitretinoin in the treatment of severe chronic hand eczema refractory to topical therapy.
July 2010 – June 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for an observational post-marketing safety surveillance registry of Enbrel (etanercept) for the treatment of psoriasis.
July 2010 – May 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a phase II, multicenter, randomized, double-blind comparison study of FV-100 (bicyclic nucleoside analogue) with valacyclovir in patients with Herpes Zoster.
July 2010 – March 2011 Center for Clinical Studies, Houston, TX
Principal Investigator, Stephen K. Tyring, MD, PhD, MBA
Sub-investigator for a multicenter, double-blind, randomized, placebo controlled, dose-finding trial to investigate different doses of a new antiviral drug (helicase- primase inhibitor) in subjects with genital HSV type 2 infection.
September 2008 – November 2008 University at Rochester, Rochester, NY
Principal Investigator, Julie Ryan, PhD
Research assistant for the study of curcumin for the treatment of radiation induced dermatitis. Performed dermatitis grading of clinical trial patients. Basic science research including: skin preparation and harvesting of primary keratinocytes, protein arrays, western blot, PCR, immuno-histochemistry, weaning of mice, DNA gel electrophoresis for mice genotyping, treatment of mice with intragastric therapy, gamma radiation with a cesium source of mice and cell lines.
June 2006 – August 2006 Buffalo Medical Group, Buffalo, NY
Principal Investigator, Robert Kalb, MD
Research assistant for the retrospective study of biologic therapies for severe psoriasis. Analyzed the efficacy of using biologic therapy after patients initially failed on one biologic.
September 2004 – May 2005 SUNY Geneseo ,Geneseo, NY
Principal Investigator, Robert O’Donnell, PhD
Research assistant for studies of human breast cancer cells grown in vitro, analyzing the effects of an aromatase inhibitor and a protease inhibitor. Cell cultures of various cell lines including melanoma.
Haitz K, Patel A, Baughman R. Periorbital subcutaneous emphysema mistaken for angioedema after dental crown preparation. JAMA Dermatol. 2014 Aug;150(8):907-9.
Haitz, KA, Seidel GD, Chapman MS. Intralymphatic histiocytosis associated with an orthopedic metal implant. Accepted to Cutis March 2013.
Mendoza N, Hernandez PO, Tyring SK, Haitz KA, Motta A. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia. Int J Dermatol. 2013 Jun;52(6):688-92.
Haitz KA, Rady PL, Nguyen HP, He Q, Prieto VG, Tyring SK, Ciurea AM. Merkel cell polyomavirus DNA detection in a patient with merkel cell carcinoma and multiple other skin cancers. Int J Dermatol. 2012 Apr; 51(4): 442-4.
Magel GD, Haitz KA, Lapolla WJ, DiGiorgio KM & Tyring SK. (2012). Systemic antiviral agents. In SE Wolverton (Ed.), Wolverton’s Comprehensive Dermatologic Drug Therapy.
Orlando, FL. Saunders.
Nagel MA, Choe A, Cohrs RJ, Traktinskiy I, Sorensen K, Mehta SK, Pierson DL, Tyring SK, Haitz K, Digiorgio C, Lapolla W, Gilden D. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis. 2011 Sep 15;204(6):820-4.
Magel GD, Mendoza N, Digiorgio CM, Haitz KA, Lapolla WJ, Tyring SK.Vaccines in dermatological diseases. G Ital Dermatol Venereol. 2011 Jun;146(3):225-33.
Lapolla W, Digiorgio C, Haitz K, Magel G, Mendoza N, Grady J, Lu W, Tyring S. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol. 2011 Aug;147(8):901-7.
Haitz KA, Mendoza N, Magel GD, DiGiorgio CM, Lapolla WJ, & Tyring SK. (2010). Varicella. In Heymann WR, Hivnor C, Lessin SR (Ed.), Clinical Decision Support: Dermatology.
Wilmington, DE. Decision Support in Medicine.
DiGiorgio CM, Magel GD, Haitz KA, Mendoza N, Lapolla WJ, & Tyring SK. (2010).
Cytomegalovirus In Heymann WR, Hivnor C, Lessin SR (Ed.), Clinical Decision Support: Dermatology.
Wilmington, DE. Decision Support in Medicine.
Lapolla WJ, Haitz KA, Mendoza N, Magel GD, DiGiorgio CM, & Tyring SK. (2010). Herpes Zoster. In Heymann WR, Hivnor C, Lessin SR (Ed.), Clinical Decision Support: Dermatology.
Wilmington, DE. C Decision Support in Medicine.
Magel GD, DiGiorgio CM, Haitz KA, Lapolla WJ, Mendoza N, & Tyring SK. (2010). Herpes Simplex. In Heymann WR, Hivnor C, Lessin SR (Ed.), Clinical Decision Support: Dermatology.
Wilmington, DE. Decision Support in Medicine.
Mendoza N, DiGiorgio CM, Haitz KA, Lapolla WJ, Magel GD, & Tyring SK. (2010).
Chromoblastomycosis. In Heymann WR, Hivnor C, Lessin SR (Ed.), Clinical Decision Support: Dermatology.
Wilmington, DE. Decision Support in Medicine.
Haitz KA, Tyring SK. Photoquiz: An HIV Positive Male with a Herald Plaque. Clinical Infectious Diseases 2011 52: 826-827.
Haitz KA, Kalb RE. Infliximab in the treatment of psoriasis in patients previously treated with etanercept. J Am Acad Dermatol. 2007 Jul;57(1):120-5.
Kassie Haitz. Psychodermatology: A Practical Guide for Dermatologists. Oral Presentation, Dartmouth-Hitchcock Dermatology Grand Rounds. December 2014. Lebanon, NH
Kassie Haitz. The Dermatologist’s Guide to Scar Management. Oral Presentation, Dartmouth- Hitchcock Dermatology Grand Rounds. May 2014. Lebanon, NH
Kassie Haitz. Pigmented Lesions in the Pediatric Population. Oral Presentation, Dartmouth- Hitchcock Dermatology Grand Rounds. February 2013. Lebanon, NH
Kassie Haitz. Intralymphatic Histiocytosis Associated with an Orthopedic Metal Implant. Oral presentation, 71st Annual Meeting American Academy of Dermatology Gross and Micro Dermatology Symposium, March 2013. Miami, FL.
Natalia Mendoza, Manuel Franco, Kassie A. Haitz, Stephen K. Tyring, Adriana Motta Antibiotic susceptibility profiles in Staphylococcus aureus from patients with atopic dermatitis and their caregivers in a Colombian population. Poster presentation, 22nd World Congress of Dermatology. May 2011. Seoul, Korea
Kassie Haitz, Peter Rady, Harrison Nyugen, Stephen Tyring, Ana Ciurea. Merkel cell polymovirus DNA detection in a patient with Merkel cell carcinoma and multiple other skin cancers. Oral presentation, American Academy of Dermatology Late-Breaking Research Symposium, February 2011. New Orleans, LA.
Kassie Haitz The Herald Patch: An Unusual Presentation of Secondary Syphilis. Oral presentation, Houston Dermatological Society Meeting, August 2010. Houston, TX.
Kassie Haitz. Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis. Oral presentation, University at Buffalo, Department of Medicine, Critical Care Lecture Series, May 2010. Buffalo, NY.
Kassie Haitz. Skin Problems & Pain in Cancer Patients Receiving Radiation Treatment. Oral presentation, University at Rochester, Department of Dermatology, Research Data Lectures, November 2008. Rochester, NY.
Kassie Haitz. Case Presentation and Review of Pachyonychia Congenita. Oral Presentation, University at Buffalo, Department of Dermatology Grand Rounds, September 2008. Buffalo, NY.
Haitz K, Titus L, Caruso R, Scott M, O’Donnell R. The Effects of an aromatase inhibitor and a protease inhibitor on human breast cancer cells grown in vitro. Poster Presentation, SUNY Geneseo Research Symposium. April 2005. Geneseo, NY.
Highland Hospital, URMC
Rochester NY